HealthEquity (NASDAQ:HQY) Hits New 52-Week High - Still a Buy?

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $107.89 and last traded at $107.55, with a volume of 352393 shares. The stock had previously closed at $104.34.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HQY. The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective for the company. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research report on Tuesday, December 10th. Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price for the company. Finally, Barrington Research lifted their target price on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.71.

HealthEquity Trading Down 0.1 %

The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business's fifty day simple moving average is $100.09 and its two-hundred day simple moving average is $88.45. The company has a market cap of $9.57 billion, a price-to-earnings ratio of 101.30, a PEG ratio of 1.91 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the firm posted $0.40 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares of the company's stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,289 shares of company stock worth $3,355,718. Insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the business. Paladin Wealth LLC acquired a new position in shares of HealthEquity during the 3rd quarter worth $39,000. UMB Bank n.a. raised its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of HealthEquity during the 2nd quarter worth $73,000. GAMMA Investing LLC raised its stake in shares of HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after buying an additional 344 shares during the last quarter. Finally, Quarry LP raised its stake in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.